Grantham, Mayo, Van Otterloo & Co (GMO)
VTRS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Viatris VTRS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-445,161
Closed -$3.98M – 659
2025
Q2 		$3.98M Sell
445,161
-2,435,516
-85% -$20.6M 0.01% 317
2025
Q1 		$25.1M Buy
2,880,677
+335,123
+13% +$3.52M 0.08% 164
2024
Q4 		$31.7M Sell
2,545,554
-1,004,312
-28% -$12.3M 0.1% 129
2024
Q3 		$41.2M Buy
3,549,866
+526,341
+17% +$6.07M 0.13% 109
2024
Q2 		$32.1M Sell
3,023,525
-514,378
-15% -$5.68M 0.11% 127
2024
Q1 		$42.2M Sell
3,537,903
-614,836
-15% -$7.41M 0.15% 93
2023
Q4 		$45M Buy
4,152,739
+581,574
+16% +$5.57M 0.2% 91
2023
Q3 		$35.2M Buy
3,571,165
+195,651
+6% +$2.04M 0.17% 111
2023
Q2 		$33.7M Sell
3,375,514
-493,280
-13% -$4.71M 0.16% 116
2023
Q1 		$37.2M Buy
3,868,794
+189,500
+5% +$2.1M 0.19% 102
2022
Q4 		$41M Buy
3,679,294
+647,094
+21% +$6.76M 0.22% 89
2022
Q3 		$25.8M Buy
3,032,200
+398,400
+15% +$3.92M 0.15% 142
2022
Q2 		$27.6M Buy
2,633,800
+109,000
+4% +$1.19M 0.15% 142
2022
Q1 		$27.5M Buy
2,524,800
+754,100
+43% +$9.94M 0.13% 141
2021
Q4 		$24M Sell
1,770,700
-132,400
-7% -$1.77M 0.12% 141
2021
Q3 		$25.8M Buy
1,903,100
+292,400
+18% +$4.15M 0.13% 140
2021
Q2 		$23M Buy
1,610,700
+308,911
+24% +$4.47M 0.11% 149
2021
Q1 		$18.2M Buy
1,301,789
+644,032
+98% +$10.5M 0.1% 164
2020
Q4 		$12.3M Buy
657,757
+628,295
+2,133% +$10.2M 0.08% 185
2020
Q3 		$437K Buy
+29,462
New +$470K ﹤0.01% 640

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s VTRS Position: Q3 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Viatris (VTRS) in Q3 2025, closing a stake of 445,161 shares — an estimated $3.98M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VTRS in Q3 2020 and held it in 20 quarters. The position peaked at $45M in Q4 2023. 972 funds tracked by Wall St. Rank hold VTRS as of Q3 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Viatris position as of Q3 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 445,161 Viatris shares in Q3 2025, an estimated $3.98M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Viatris in Q3 2020 and held it in 20 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Viatris position peaked at $45M in Q4 2023.
  • 972 funds tracked by Wall St. Rank held Viatris as of Q3 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.